-
Company Profile
Orexo AB – Company Profile
Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company’s commercial product portfolio consists of Abstral, Edluar, and Zubsolv. The company develops its products based on its proprietary drug delivery technology, namely, sublingual tablet technology. The sublingual tablet rapidly disintegrates and dissolves, allowing the medicine to be directly absorbed into the bloodstream through the mucous membrane. It also carries out the industrial-scale production of pharmaceutical products. Orexo collaborates...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OX-640
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry OX-640 Drug Details Epinephrine is under development for the treatment of allergic reactions, including...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ketorolac
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ketorolac Drug Details Ketorolac (MDL-002) is under development for the treatment of pain. It...
-
Product Insights
Anaphylaxis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Anaphylaxis Pipeline Drugs Market Overview Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma and family history. Treatment includes beta-agonist, antihistamines and cortisone. The Anaphylaxis pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target,...
-
Product Insights
Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Drug Overdose can occur with multiple symptoms including sleepiness, confusion, chest pain, seizures, abdominal pain, nausea, vomiting, and diarrhea. Treatment includes antidote and activated charcoal. The Drug Overdose pipeline market report provides a comprehensive overview of the therapeutics under development for Drug Overdose, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history,...
-
Product Insights
Opium (Opioid) Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Opium (Opioid) Addiction develops after using opioids regularly for a period. Prolonged use of opiates can lead to nerve damage within the brain that causes cells to stop producing endogenous opiates (natural painkillers known as endorphins). Its signs and symptoms include increased general anxiety, euphoria, psychosis, depression, high blood pressure, decreased appetite, physical agitation, difficulty sleeping, and pain in the bones. The predisposing factors include age, personal history/ family history of substance abuse, cigarette dependency, and psychological stress. The Opium...
-
Product Insights
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Opium (Opioid) Addiction clinical trial market research report provides an overview of the Opium (Opioid) Addiction clinical trials scenario. The report provides top-line data relating to the clinical trials on Opium (Opioid) Addiction. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Product Insights
Drug Overdose Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Drug Overdose Global Clinical Trials Review, H1, 2019" provides an overview of Drug Overdose clinical trials scenario. This report provides top line data relating to the clinical trials on Drug Overdose. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Age Related Memory Impairment Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Age Related Memory Impairment Global Clinical Trials Review, H2, 2018" provides an overview of Age Related Memory Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Memory Impairment. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Memory Impairment Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Memory Impairment Global Clinical Trials Review, H2, 2017" provides an overview of Memory Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Memory Impairment. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...